Effect of Hyperbaric Oxygen Therapy
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this tudy will be to investigate the effects of a single session of hyperbaric oxygen therapy (HBOT) on recovery and performance after a football match in elite youth football players. The main questions this study will aim to answer are: Will a single session of HBOT improve recovery parameters such as biochemical markers and physical fitness in elite youth football players after a football match? Will a single session of HBOT enhance the performance of elite youth football players after a football match? Participants in this study will include twenty elite youth male football players. They will be randomly assigned to either the HBOT group or the control group. All participants will undergo evaluations for biochemical parameters, physical fitness tests, and the Hooper Index (HI) at multiple time points: before the match, at the end of the match, one hour after the HBOT session, and 12 hours after the HBOT session. In the HBOT group, participants will receive 100% oxygen under elevated pressure in a hyperbaric chamber for a duration of 70 minutes immediately after the football match. Meanwhile, the control group will be exposed to normal atmospheric pressure. Biochemical analysis will involve collecting blood samples to measure markers such as myoglobin, creatine kinase, lactate dehydrogenase, alanine aminotransferase, and aspartate aminotransferase. Physical fitness tests will include vertical jump height measurements (squat jump, countermovement jump, and countermovement jump with arm swing) and linear speed assessments at various distances (5 m, 10 m, and 20 m). The Hooper Index (HI) will be used for subjective assessment of fatigue and well-being. This study aims to provide insights into the potential benefits of HBOT as a recovery strategy for elite youth football players and its impact on performance in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2023
CompletedFirst Submitted
Initial submission to the registry
October 18, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedNovember 1, 2023
October 1, 2023
15 days
October 18, 2023
October 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Myoglobin
Measure of myoglobin concentration in blood. Myoglobin will be determined using Siemens IMMULITE 1000 (Siemens Healthcare Diagnostics, UK).
baseline, 3 hours, 5 hours, 24 hours
Creatine kinase
Measure of creatine kinase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).
baseline, 3 hours, 5 hours, 24 hours
Lactate dehydrogenase
Measure of lactate dehydrogenase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).
baseline, 3 hours, 5 hours, 24 hours
Alanine aminotransferase
Measure of alanine aminotransferase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).
baseline, 3 hours, 5 hours, 24 hours
Aspartate aminotransferase
Measure of aspartate aminotransferase concentration in blood. It will be analyzed using a biochemistry analyzer (A25 Biosystems Chemistry Analyzer).
baseline, 3 hours, 5 hours, 24 hours
Secondary Outcomes (6)
Squat jump
baseline, 3 hours, 5 hours, 24 hours
Countermovement jump
baseline, 3 hours, 5 hours, 24 hours
Countermovement jump with arm swing
baseline, 3 hours, 5 hours, 24 hours
5 meter linear speed
baseline, 3 hours, 5 hours, 24 hours
10 meter linear speed
baseline, 3 hours, 5 hours, 24 hours
- +1 more secondary outcomes
Study Arms (2)
HBOT group
EXPERIMENTALCON group
PLACEBO COMPARATORInterventions
The HBOT will be performed in a Barox HBOT chamber (Yaklasim Makina San. Ve Tic. Ltd. Sti). Participants will be taken to the chamber immediately after the football match, where they will sit in individual chairs, and oxygen will be delivered through individual masks. The HBOT group will be exposed to 100% oxygen at 2.2 ATA (atmospheres absolute). Session will last 70 minutes.
The placebo protocols will be performed in a Barox HBOT chamber (Yaklasim Makina San. Ve Tic. Ltd. Sti). Participants will be taken to the chamber immediately after the football match, where they will sit in individual chairs, and oxygen will be delivered through individual masks. The CON group will be exposed to normobaric ambient pressure (1 ATA). The session will last 70 minutes.
Eligibility Criteria
You may qualify if:
- football player
- free of injuries
- free of medical conditions contraindicated by hyperbaric oxygen therapy (HBOT)
- written parental consent
You may not qualify if:
- pre-existing injuries or medical conditions that are contraindicated by hyperbaric oxygen therapy (HBOT)
- participation in severe physical activity within 24 hours before the study
- participants who do not comply with the requirement to abstain from breakfast, caffeine, and alcohol prior to the first blood collection
- an active respiratory illness, such as a cold, at the time of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hyperbaric center Subotica
Subotica, Serbia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2023
First Posted
November 1, 2023
Study Start
May 20, 2023
Primary Completion
June 4, 2023
Study Completion
June 6, 2023
Last Updated
November 1, 2023
Record last verified: 2023-10